Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • kerplunk412
    Senior Member
    • Jun 2012
    • 119

    #16
    Originally posted by francicco View Post
    Thank you K.

    So which kit do you would suggest? Or which company...

    F
    Sorry I didn't respond to this earlier. The NEXTflex PCR-Free DNA-Seq kit from Bioo Scientific is what I would recommend, but please note that I work for Bioo Scientific. I believe Illumina and a couple of other companies offer similar kits. Feel free to PM me if you would like more information.

    No matter which company you go with, I highly recommend PCR-free, using Covaris to shear your DNA. This eliminates concern of insertion bias and PCR bias, and I am fairly sure PCR-free is generally accepted to show the most even coverage over AT and GC rich regions. If you can get 100-200 ng of DNA from an individual I think PCR-free or very low cycle PCR library prep from an individual is feasible.

    Comment

    • SNPsaurus
      Registered Vendor
      • May 2013
      • 525

      #17
      I would definitely be concerned with the presence of gut bacteria and endosymbionts. We do a lot of small insect genotyping by sequencing, and small insects have a higher probability of having lots of food DNA, gut bacteria, Wolbachia... you name it.

      Can you get embryos from one female? A little heterozygosity would pale in comparison to having 2/3rds your reads go to species different from the one you are interested in assembling. Heads are another option. Samples sourced from heads have been very clean.
      Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

      Comment

      • Hamid
        Senior Member
        • Sep 2009
        • 108

        #18
        Hi Francicco,

        Shearing DNA with Covaris AFA is concentration independent. You can optimize your desired shearing size range and distribution using a higher concentration of ~1g of any control DNA, and then use the same settings to shear your limited mass DNA.

        Thank you

        Hamid

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        212 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...